Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07605338 · ClinicalTrials.gov registry record · Phase 3
To Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis.
A Phase 3 study, sponsored by Colgate Palmolive.
- Active
- Registry status
- Phase 3
- Development phase
- 85
- Enrollment target
NCT07605338: Active Phase 3 study, sponsored by Colgate Palmolive.
NCT07605338 is a Phase 3 study that is active but no longer recruiting, run by Colgate Palmolive. The registered enrollment target is 85 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07605338, a Phase 3 study, is active but no longer recruiting, sponsored by Colgate Palmolive.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 85 participants
- Enrollment target
Study Summary
Triple Blinded Randomized Clinical trial study to assess the efficacy of two brushing regimens: 1) a toothpaste containing stannous fluoride and a standard manual toothbrush as compared to 2) a regular fluoride toothpaste and standard manual toothbrush in the reduction of established dental plaque and gingivitis.
Primary Outcome
score from 0 to 3 will be assigned by the examining dentist Each tooth is scored on six surfaces: mesio-facial; 2) mid-facial; 3) disto-facial; 4) mesiolingual; 5) mid-lingual; and 6) disto-lingual
Interventions
- DRUG Colgate SNaP Total 10/10, 1.5 Taurate
- DRUG Colgate Great Regular Flavor Toothpaste
- OTHER Flat Trimmed Extra Clean TB
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2026-05-11 |
| Est. Completion | 2026-11 |
| Phase | Phase 3 |
What the registry record for NCT07605338 still lists
NCT07605338 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Colgate SNaP Total 10/10, 1.5 Taurate is the first listed.
NCT07605338 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07605338 about?
NCT07605338 is a clinical study titled "To Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis.". Triple Blinded Randomized Clinical trial study to assess the efficacy of two brushing regimens: 1) a toothpaste containing stannous fluoride and a standard manual toothbrush as compared to 2) a regular fluoride toothpaste and standard manual toothbrush in the reduction of established dental plaque a...
What is the current status of trial NCT07605338?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 85 participants. The study started on 2026-05-11. Estimated completion is 2026-11.
What interventions are being tested in trial NCT07605338?
The interventions under investigation include: Colgate SNaP Total 10/10, 1.5 Taurate (DRUG), Colgate Great Regular Flavor Toothpaste (DRUG), Flat Trimmed Extra Clean TB (OTHER).
Who is sponsoring clinical trial NCT07605338?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07605338's enrollment target sits among peer trials
85 1747th of 2000 higher than 252 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI